New test aims to improve doctor decisions for chronic illness
NCT ID NCT05192590
First seen Feb 28, 2026 · Last updated Jun 19, 2026 · Updated 21 times
Summary
This study looked at whether a new test (CDMT) helps primary care doctors make better decisions for patients with cardiometabolic syndrome. 247 board-certified physicians participated, with some using the test and others not. Researchers measured the quality of care and expected costs to see if the test improves patient management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMETABOLIC SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
QURE Healthcare
San Francisco, California, 94109, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.